Development of inhalable extra-fine particles of vancomycin for the treatment of pulmonary methicillin-resistant Staphylococcus aureus infections
{{output}}
Pulmonary infections caused by Methicillin-resistant Staphylococcus aureus represent a major therapeutic challenge, highlighting the need for efficient local antibiotic delivery. This study aimed to develop an extra-fine dry powder inhaler (DPI) formulation co... ...
